Prime Medicine
PRME
Prime Medicine (PRME) news
Recent news
Prime Medicine, Inc: expects cash and investments as of June 30, 2026 sufficient to fund operations into 2027
Prime Medicine, Inc. (Nasdaq: PRME) reported in its first-quarter 2026 financial results that its cash, cash equivalents, investments , and restricted cash totaled $149.2 million as of March 31, 2026. Based on its current operating plans, the company expects these funds to be support its operating…
AInvest Wire · Aug 6, 2026Prime Medicine owes no monetary damages to Beam Therapeutics
AInvest Wire · Jul 8, 2026Prime Medicine: plans to submit IND and/or CTA filing in 3Q
AInvest Wire · Jul 8, 2026Prime Medicine reports positive resolution to arbitration
AInvest Wire · Jul 8, 2026Prime Medicine announces positive resolution to arbitration with Beam Therapeutics
AInvest Wire · Jul 8, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.